CINECA IRIS Institutional Research Information System

GADDUCCI, ANGIOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 45.726
AS - Asia 30.994
EU - Europa 23.715
SA - Sud America 3.387
Continente sconosciuto - Info sul continente non disponibili 584
AF - Africa 540
OC - Oceania 35
Totale 104.981
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 43.817
CN - Cina 9.914
IT - Italia 9.609
SG - Singapore 9.106
HK - Hong Kong 4.581
SE - Svezia 2.904
BR - Brasile 2.838
KR - Corea 2.303
VN - Vietnam 2.016
UA - Ucraina 1.997
BG - Bulgaria 1.981
CA - Canada 1.559
DE - Germania 1.335
GB - Regno Unito 1.174
TR - Turchia 1.146
FR - Francia 1.144
FI - Finlandia 1.002
CH - Svizzera 903
RU - Federazione Russa 872
IN - India 433
JP - Giappone 375
BD - Bangladesh 212
AR - Argentina 195
NL - Olanda 154
IQ - Iraq 142
MX - Messico 111
ES - Italia 108
ZA - Sudafrica 100
PK - Pakistan 93
SA - Arabia Saudita 93
BE - Belgio 91
ID - Indonesia 91
VE - Venezuela 82
UZ - Uzbekistan 72
AT - Austria 71
CO - Colombia 67
EC - Ecuador 66
MA - Marocco 65
CI - Costa d'Avorio 61
PL - Polonia 58
JM - Giamaica 48
SN - Senegal 47
IE - Irlanda 46
CR - Costa Rica 45
PH - Filippine 45
KE - Kenya 44
NG - Nigeria 43
CZ - Repubblica Ceca 41
JO - Giordania 39
EG - Egitto 38
BJ - Benin 35
PY - Paraguay 35
RO - Romania 35
CL - Cile 32
MY - Malesia 31
AE - Emirati Arabi Uniti 30
PT - Portogallo 28
TT - Trinidad e Tobago 28
AU - Australia 27
IL - Israele 27
BO - Bolivia 25
NP - Nepal 25
TN - Tunisia 25
HN - Honduras 24
GR - Grecia 23
HU - Ungheria 22
OM - Oman 22
UY - Uruguay 21
AZ - Azerbaigian 20
LB - Libano 19
PE - Perù 19
TH - Thailandia 19
TW - Taiwan 18
GT - Guatemala 17
DO - Repubblica Dominicana 16
DZ - Algeria 16
LT - Lituania 16
AL - Albania 15
EE - Estonia 15
ET - Etiopia 15
IR - Iran 15
KG - Kirghizistan 15
KZ - Kazakistan 14
RS - Serbia 13
NI - Nicaragua 12
HR - Croazia 11
DK - Danimarca 10
EU - Europa 10
PA - Panama 9
QA - Qatar 9
KW - Kuwait 8
AO - Angola 7
PS - Palestinian Territory 7
BB - Barbados 6
BH - Bahrain 6
BS - Bahamas 6
CY - Cipro 6
MN - Mongolia 6
NZ - Nuova Zelanda 6
AM - Armenia 5
Totale 104.258
Salva come PNG Salva come JPEG
Città #
Singapore 5.236
Ashburn 4.681
Hong Kong 4.532
Milan 3.798
Chandler 3.225
Hefei 3.192
Jacksonville 2.704
Woodbridge 2.683
Ann Arbor 2.524
San Jose 2.500
Seoul 2.296
Fairfield 2.249
Dallas 2.176
Sofia 1.975
Houston 1.949
Shanghai 1.560
Ottawa 1.363
Council Bluffs 1.337
Beijing 1.316
New York 1.210
Santa Clara 1.077
Seattle 1.011
Wilmington 884
Boardman 867
Bern 845
Princeton 801
Lawrence 775
Nanjing 772
Cambridge 685
Lauterbourg 668
Izmir 632
Des Moines 620
Los Angeles 610
Medford 596
Dearborn 503
Jüchen 475
Ho Chi Minh City 465
Rome 393
Buffalo 391
Istanbul 378
Tokyo 341
Dong Ket 330
Hanoi 323
Nanchang 265
Helsinki 257
São Paulo 238
Redwood City 225
Kunming 200
San Diego 176
Boulder 154
Redondo Beach 152
Orem 135
Shenyang 134
Ogden 132
Frankfurt am Main 128
London 115
Changsha 114
Florence 114
Tianjin 113
Hebei 108
Munich 108
Chicago 102
Jiaxing 91
Brussels 86
Verona 84
Da Nang 83
Lancaster 83
Norwalk 79
Rio de Janeiro 78
Orange 76
Serra 72
Tashkent 68
Chennai 65
Columbus 65
Guangzhou 65
Düsseldorf 64
Pune 63
Hangzhou 62
The Dalles 62
Abidjan 60
Belo Horizonte 60
Baghdad 59
Turin 59
Brasília 58
Dhaka 56
Pisa 56
Atlanta 52
Vienna 52
Montreal 51
Washington 50
Detroit 48
Fuzhou 47
Curitiba 46
Dakar 46
Haiphong 44
Porto Alegre 43
Changchun 42
Falls Church 42
Jinan 42
Manchester 42
Totale 72.219
Salva come PNG Salva come JPEG
Nome #
Chemioterapia con CTX,DDP,ADM nel carcinoma ovarico in stadio avanzato 1.911
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score 972
Isterectomia radicale secondo Wertheim-Meigs e radioterapia transcutanea postoperatoria con alte energie nel trattamento del carcinoma cervicale negli stadi Ib-II FIGO 421
Factors in malignant transformation of ovarian endometriosis: A narrative review 376
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 344
Alfa2-macroglobulina e dismetabolismo glicidico in gravidanza 262
A comparison of several tumor markers in the diagnosis, monitoring and follow-up of patients with epithelial ovarian cancer 255
Chemioterapia neoadiuvante con schema PVB nel carcinoma cervicale avanzato. 252
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study 237
D-dimer in gynecological cancer 225
Endometrial stromal sarco¬ma: Analysis of treatment failures and survival 225
Il recettore solubile dell' interleuchina-2(sIL-2r) nel carcinoma ovarico 222
Functional Interaction Between BRCA1 and DNA Repair in Yeast May Uncover a Role of RAD50, RAD51, MRE11A, and MSH6 Somatic Variants in Cancer Development. 221
Combined use of CA125 and CA15-3 in patients with endometrial carcinoma. 217
Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: Is local therapy with hyaluronic acid of clinical benefit? 216
Carboplatin, doxorubicin and cyclophosphamide versus cisplatin, doxorubicin and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma. 215
Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer 214
Prognostic value of lymph node status and number of removed nodes in patients with squamous cell carcinoma of the vulva treated with modified radical vulvectomy and inguinal-femoral lymphadenectomy. 211
Computerized tomography (CT) semeiotics in the presurgical evaluation of gynaecological neoplasias. 211
Porphyrin-sensitized phototreatment as a conservative therapy in gynaecological oncology 210
Computed tomography in the follow-up of gynaecological neoplasias 209
Il dosaggio sierico del recettore solubile della interleuchina-2 nelle neoplasie ginecologiche 208
La tomografia assiale computerizzata nel follow-up delle pazienti precedentemente trattate per neoplasie della cervice e del corpo uterino 204
Wertheim's radical hysterectomy with pelvic lymphadenectomy in the treatment of cervical carcinoma at the Obstetric and Gynecological Clinic of the University of Pisa 202
Prospective multicenter study on CA 125 in postmenopausal pelvic masses. 202
Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer 200
Adjuvant treatment and analysis of failures in patients with high-risk FIGO Stage Ib-II endometrial cancer: An Italian multicenter retrospective study (CTF study) 200
Carcinoma developing in bladder exstrophy. Case report. 199
Correlation of CA125 and CA19-9 serum levels with clinical course and second-look findings in patients with ovarian carcinoma 199
p53 nuclear accumulation in adenomatous hyperplasia and stage I endometrioid carcinoma. 199
Valutazione del CA125, TPA, GICA, CEA nella diagnosi e nel monitoraggio del carcinoma ovarico. 198
Micro-RNAs and ovarian cancer: The state of art and perspectives of clinical research 197
An analysis of approaches to the management of endome¬trial cancer in North America: A CTF study. 196
Follow-up strategies in gynecological oncology: searching appropriateness 195
A comparison of the usefullness of serum measurements of CA125, CA50 and TATI in patients with malignant and benign gynecological pathology 194
Brenner's tumor 193
Prothrombin fragment F 1+ 2 and thrombin- antithrombin III complex (TAT) plasma levels in patients with gynecological cancer 193
The effect of delays in cancer surgery due to the COVID-19 pandemic on cancer resectability and postoperative mortality in different tumor entities 192
Prognostic role of immunosuppres¬sive acidic protein in advanced ovarian cancer. 192
The role of the French-Italian glossary of complications in the outcome evaluation of cervical cancer treatment: an Italian multicentric study 191
Novel targeted therapies in epithelial ovarian cancer: from basic research to the clinic 191
Discontinuation of modern hormonal contraceptives: an Italian survey 189
High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest 188
Evaluation of the central dopaminergic activity in gestational hyperprolactinaemia by means of the electroretinographic technique 187
The therapy of verrucous carcinoma of the vulva. Observations on three cases. 186
Antiangiogenic agents in gynecological cancer: State of art and perspectives of clinical research 186
Gynecological malignancies in elderly patients: is age 70 a limit to standard-dose chemotherapy? An Italian retrospective toxicity multicentric study 185
Current management of fallopian tube carcinoma 183
First-line chemothe¬rapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patients 183
Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study) 183
Metabolismo glicidico ed emoglobina glicosilata (HbA1) in gravidanza 182
The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis 182
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients. 182
Clinical Outcomes of Stereotactic Body Radiotherapy in Oligometastatic Gynecological Cancer 182
Aspetti colposcopici, citologici, e istologici dell'endometriosi cervicale. 181
Adjuvant treatment of stage I-II malignant mixed mesodermal tumors (MMMT) of the uterus: a multicenter CTF study 181
Intraperitoneal chemotherapy in the management of patients with advanced epithelial ovarian cancer: a critical review of the literature 181
Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature 181
Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: A debated clinical issue 181
p53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimen. 181
Management of peritoneal carcinomatosis with cytoreductive surgery combined with intraperitoneal chemohyperthermia at a novel italian center 181
Serum solule interleukin-receptor (sIL-2R) assay in cervical an endometrial cancer. Preliminary data. 180
Preoperative evaluation of D-Dimer and CA 125 levels in differentiating benign from malignant ovarian masses. 179
Struma ovarii 178
Iperprolattinemia e stati depressivi 178
Adjuvant treatment of early stage ovarian carcinoma. 178
Factor VIIIR: Ag plasma levels in patients with cervical and ovarian carcinoma 178
Fattori prognostici nei tumori misti mulleriani maligni (MMMT) dell' utero al I-II stadio: uno studio CTF 178
Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer. 178
Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer. 178
Pharmacological treatment for uterine leiomyosarcomas 178
The role of computerized tomography of the pelvis in the presurgical staging of carcinoma of the cervix and of the ovary Eur.J. Gynaec. 177
Porfirine e luce visibile nella diagnosi e nella terapia delle neoplasie. Prime esperienze cliniche in oncologia ginecologica. 177
A comparative evaluation of the ability of serum CA125, CA19-9, CA15-3, CA50, CA72-4 and TATI assays in reflecting the course of disease in patients with ovarian carcinoma 177
Assenza di alterazioni dell'oncogene MDM-2 nel carcinoma ovarico 177
Uterine leiomyosarcoma: Analysis of treatment failures and survival 177
Minimization of cisplatin nephrotoxicity in high-risk patients 176
Epidoxorubicin (EPI-DX) and lonidamine (LND) in refractory or recurrent epithelial ovarian cancer (EOC) 175
Serum half-life of CA 125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer: results of a multicentric Italian study 175
Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer 175
Weekly epirubicin in the treatment of gestational breast cancer (GBC) 175
Hemorrhagic uterine necrosis after surgical vessel ligation and B-Lynch suture in persistent post-cesarean uterine atony: case report and review of literature 175
Le complicanze postoperatorie dell'intervento di laparoisterectomia radicale con linfadenectomia pelvica 174
Sistema immunitario e carcinoma ovarico 174
A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinoma. 173
A combination of CA125, CA19-9, CA15-3, CA50, CA72-4 and TATI in the monitoring of ovarian carcinoma 173
Surgery and radiotherapy in the treatment of early stage uterine sarcomas. 173
Iperespressione della proteina p53 nella iperplasia endometriale e nel carcinoma endonmetriale in I stadio 173
Presidi farmacologici nel controllo dell'emesi indotta dalla chemioterapia per neoplasie maligne ginecologiche 172
Verrucous carcinoma of the cervix 172
The concomitant determination of different serum tumor markers in epithelial ovarian cancer: relevance for monitoring the response to chemotherapy and follow-up of patients 172
Carcinosarcoma of the uterus : a clinicopathological multicenter CTF study 172
Management of borderline ovarian tumors: Results of an Italian multicenter study 172
Evaluation of FHIT gene alterations in ovarian cancer 172
Squamous cell carcinoma of the vagina: Natural history, treatment modalities and prognostic factors 172
The topical administration of steroids in the treatment of typical vulvar dystrophy. 171
P53 overexpression in ovarian cancer: correlation with clinicopathological parameters and chemosensitivity 171
Analysis of failures in patients with stage I ovarian cancer: an Italian multicenter study 171
Fertility drug use and risk of ovarian tumors: a debated clinical challenge 170
Prognostic factors in uterine sarcoma 169
Totale 22.051
Salva come PNG Salva come JPEG
Categoria #
all - tutte 293.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 293.285
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.474 0 545 307 678 1.516 1.000 189 360 281 148 344 2.106
2022/20238.048 1.124 683 424 699 1.172 1.282 115 727 1.124 58 531 109
2023/202410.127 1.958 1.282 1.654 828 1.404 1.301 266 302 169 121 135 707
2024/202521.707 149 1.021 226 1.116 958 1.255 1.727 1.287 2.161 2.959 3.334 5.514
2025/202623.762 1.864 4.439 3.375 1.856 1.681 2.376 3.419 992 942 1.897 628 293
2026/20272.580 549 2.031 0 0 0 0 0 0 0 0 0 0
Totale 104.981